Therapeutic Advances in Drug Safety

Titel Veröffentlichungsdatum Sprache Zitate
Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem2014/10/16English900
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review2014/02/13English427
Predicting risk of adverse drug reactions in older adults2015/11/16English241
Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource2012/02/02English215
Naloxone dosage for opioid reversal: current evidence and clinical implications2017/12/13English203
Drug-induced QT interval prolongation: mechanisms and clinical management2012/07/26English192
An overview of prevalence, determinants and health outcomes of polypharmacy2020/01/01English173
Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies2013/05/20English134
Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence2017/06/29English128
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine2018/02/06English119
The risks of long-term use of proton pump inhibitors: a critical review2018/11/19English117
Nonmedical prescribing: where are we now?2016/04/29English115
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain2013/09/20English111
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access2015/01/26English107
Safety of antiobesity drugs2013/05/23English107
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications2013/03/25English101
Medication-overuse headache: epidemiology, diagnosis and treatment2014/02/06English95
Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks2014/08/28English89
Safety of dipeptidyl peptidase 4 inhibitors: a perspective review2014/02/10English85
New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?2011/06/22English81
An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine2018/01/08English79
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future2020/01/01English78
Immunogenicity and other problems associated with the use of biopharmaceuticals2011/05/10English74
Routine deprescribing of chronic medications to combat polypharmacy2015/11/03English74
Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors2014/04/21English73
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem2016/10/01English72
Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications2017/02/10English68
Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences2019/01/01English66
Safety of statins: an update2012/02/23English63
Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review2018/07/12English61